Logo image of BELYS.BR

BELYSSE GROUP NV (BELYS.BR) Stock Fundamental Analysis

EBR:BELYS - Euronext Brussels - BE0974314461 - Common Stock - Currency: EUR

0.71  -0.08 (-9.55%)

Fundamental Rating

4

BELYS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 33 industry peers in the Household Durables industry. While BELYS is still in line with the averages on profitability rating, there are concerns on its financial health. BELYS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BELYS had positive earnings in the past year.
In the past year BELYS had a positive cash flow from operations.
BELYS had negative earnings in 4 of the past 5 years.
Of the past 5 years BELYS 4 years had a positive operating cash flow.
BELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFBELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.30%, BELYS is in line with its industry, outperforming 48.48% of the companies in the same industry.
BELYS has a better Return On Equity (11.07%) than 60.61% of its industry peers.
BELYS has a Return On Invested Capital of 7.18%. This is comparable to the rest of the industry: BELYS outperforms 51.52% of its industry peers.
BELYS had an Average Return On Invested Capital over the past 3 years of 7.16%. This is significantly below the industry average of 17.06%.
The 3 year average ROIC (7.16%) for BELYS is below the current ROIC(7.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.3%
ROE 11.07%
ROIC 7.18%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.16%
ROIC(5y)6.01%
BELYS.BR Yearly ROA, ROE, ROICBELYS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

Looking at the Profit Margin, with a value of 3.77%, BELYS is in line with its industry, outperforming 48.48% of the companies in the same industry.
With a decent Operating Margin value of 8.15%, BELYS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
BELYS's Operating Margin has declined in the last couple of years.
BELYS's Gross Margin of 60.82% is fine compared to the rest of the industry. BELYS outperforms 78.79% of its industry peers.
BELYS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.15%
PM (TTM) 3.77%
GM 60.82%
OM growth 3Y-4.8%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
BELYS.BR Yearly Profit, Operating, Gross MarginsBELYS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BELYS is destroying value.
The number of shares outstanding for BELYS remains at a similar level compared to 1 year ago.
The debt/assets ratio for BELYS has been reduced compared to a year ago.
BELYS.BR Yearly Shares OutstandingBELYS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
BELYS.BR Yearly Total Debt VS Total AssetsBELYS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.34, we must say that BELYS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.34, BELYS is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
The Debt to FCF ratio of BELYS is 5.56, which is a neutral value as it means it would take BELYS, 5.56 years of fcf income to pay off all of its debts.
BELYS's Debt to FCF ratio of 5.56 is fine compared to the rest of the industry. BELYS outperforms 63.64% of its industry peers.
BELYS has a Debt/Equity ratio of 1.64. This is a high value indicating a heavy dependency on external financing.
BELYS has a worse Debt to Equity ratio (1.64) than 90.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 5.56
Altman-Z 0.34
ROIC/WACC0.66
WACC10.81%
BELYS.BR Yearly LT Debt VS Equity VS FCFBELYS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.78 indicates that BELYS should not have too much problems paying its short term obligations.
BELYS has a better Current ratio (1.78) than 60.61% of its industry peers.
A Quick Ratio of 0.95 indicates that BELYS may have some problems paying its short term obligations.
With a Quick ratio value of 0.95, BELYS perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.95
BELYS.BR Yearly Current Assets VS Current LiabilitesBELYS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 193.44% over the past year.
Looking at the last year, BELYS shows a decrease in Revenue. The Revenue has decreased by -6.82% in the last year.
Measured over the past years, BELYS shows a small growth in Revenue. The Revenue has been growing by 0.43% on average per year.
EPS 1Y (TTM)193.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.25%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.64%

3.2 Future

BELYS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.00% yearly.
The Revenue is expected to grow by 1.64% on average over the next years.
EPS Next Y-58.33%
EPS Next 2Y-20.94%
EPS Next 3Y4%
EPS Next 5YN/A
Revenue Next Year1.79%
Revenue Next 2Y1.59%
Revenue Next 3Y1.64%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BELYS.BR Yearly Revenue VS EstimatesBELYS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
BELYS.BR Yearly EPS VS EstimatesBELYS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 2.45 indicates a rather cheap valuation of BELYS.
BELYS's Price/Earnings ratio is rather cheap when compared to the industry. BELYS is cheaper than 96.97% of the companies in the same industry.
BELYS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.10.
A Price/Forward Earnings ratio of 6.89 indicates a rather cheap valuation of BELYS.
BELYS's Price/Forward Earnings ratio is rather cheap when compared to the industry. BELYS is cheaper than 84.85% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BELYS to the average of the S&P500 Index (20.74), we can say BELYS is valued rather cheaply.
Industry RankSector Rank
PE 2.45
Fwd PE 6.89
BELYS.BR Price Earnings VS Forward Price EarningsBELYS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BELYS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BELYS is cheaper than 81.82% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BELYS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.85
EV/EBITDA 3.61
BELYS.BR Per share dataBELYS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.94%
EPS Next 3Y4%

0

5. Dividend

5.1 Amount

BELYS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BELYSSE GROUP NV

EBR:BELYS (5/5/2025, 7:00:00 PM)

0.71

-0.08 (-9.55%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)04-25 2025-04-25
Earnings (Next)09-05 2025-09-05
Inst Owners13.1%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap25.52M
Analysts84.44
Price Target1.63 (129.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.35%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE 2.45
Fwd PE 6.89
P/S 0.09
P/FCF 0.85
P/OCF 0.64
P/B 0.27
P/tB N/A
EV/EBITDA 3.61
EPS(TTM)0.29
EY40.85%
EPS(NY)0.1
Fwd EY14.51%
FCF(TTM)0.83
FCFY117.3%
OCF(TTM)1.12
OCFY157.27%
SpS7.8
BVpS2.66
TBVpS-0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.3%
ROE 11.07%
ROCE 8.77%
ROIC 7.18%
ROICexc 8.43%
ROICexgc 17.07%
OM 8.15%
PM (TTM) 3.77%
GM 60.82%
FCFM 10.68%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.16%
ROIC(5y)6.01%
ROICexc(3y)9.12%
ROICexc(5y)7.49%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.73%
ROCE(5y)7.33%
ROICexcg growth 3Y21.59%
ROICexcg growth 5YN/A
ROICexc growth 3Y9.46%
ROICexc growth 5YN/A
OM growth 3Y-4.8%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
F-Score6
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 5.56
Debt/EBITDA 3.69
Cap/Depr 52.09%
Cap/Sales 3.64%
Interest Coverage 1.06
Cash Conversion 94.56%
Profit Quality 283.09%
Current Ratio 1.78
Quick Ratio 0.95
Altman-Z 0.34
F-Score6
WACC10.81%
ROIC/WACC0.66
Cap/Depr(3y)58.36%
Cap/Depr(5y)60.35%
Cap/Sales(3y)3.69%
Cap/Sales(5y)3.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)193.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.25%
EPS Next Y-58.33%
EPS Next 2Y-20.94%
EPS Next 3Y4%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.64%
Revenue Next Year1.79%
Revenue Next 2Y1.59%
Revenue Next 3Y1.64%
Revenue Next 5YN/A
EBIT growth 1Y65.79%
EBIT growth 3Y-4.39%
EBIT growth 5YN/A
EBIT Next Year95.45%
EBIT Next 3Y26.94%
EBIT Next 5YN/A
FCF growth 1Y55.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.24%
OCF growth 3YN/A
OCF growth 5YN/A